Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Lymphoma | Preclinical | China | 09 Oct 2024 | |
| Ovarian Cancer | Preclinical | China | 09 Oct 2024 | |
| Small Cell Lung Cancer | Preclinical | China | 09 Oct 2024 | |
| T-Cell Lymphoma | Preclinical | China | 09 Oct 2024 |





